Strong Commercial Performance and Promising Pipeline Drive Rigel’s Buy Rating
Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Rigel (RIGL – Research Report). The associated price target ...
Brenmiller Energy Grows U.S. Commercial Pipeline to Over $210 Million in Conjunction with Distribution Partner, Rock Energy Storage
Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy" or the "Company") (Nasdaq: BNRG), a leading global energy provider ...
Hosted on MSN27d
Verrica Pharmaceuticals Reports Progress on Molluscum Treatment and Pipeline Development
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has provided an update on the commercial strategy for its ...
Nasdaq24d
Brookline starts Exelixis with Buy on commercial drugs, pipeline
The firm anticipates Exelixis will continue to develop its commercial drugs ... sees potential from the company’s earlier stage pipeline. Based on its expectation that Exelixis will grow ...
Yahoo Finance3d
PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference
Novartis will assume global development, manufacturing and commercial responsibilities following the completion of the placebo-controlled portion of PIVOT-HD, which is expected in 1H 2025.
Joplin Globe8d
Brenmiller Energy Grows U.S. Commercial Pipeline to Over $210 Million in Conjunction with Distribution Partner, Rock Energy Storage
For example, the company is using forward-looking statements in this press release when it discusses: its $210 million in value pipeline of potential commercial projects being pursued and ...
Morningstar4d
PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference
WARREN, N.J., Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2025. Matthew ...